Tag Archives: U.S.

GSK says U.S. FDA wants more information on pulmonary drug

LONDON (Reuters) – GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD). FILE PHOTO: The GlaxoSmithKline (GSK) logo. March 21, 2018. REUTERS/Loriene Perera/File Photo GSK said it had received a complete response letter (CRL) from the U.S. Food… Read More »

The New Health Care: The U.S. Is Failing in Infant Mortality, Starting at One Month Old

Another such review examined how the number of prenatal visits affected infant mortality. Seven studies involved more than 60,000 women in countries of varying income. There was no difference in high-income countries in the number of deaths of those who had more or fewer visits (although the number of deaths over all was low). In… Read More »

Amicus Therapeutics receives U.S. approval for Fabry disease drug

(Reuters) – U.S. health regulators on Friday approved Amicus Therapeutics’ Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs. Galafold, known chemically as migalastat, will be the first new Fabry treatment on the U.S. market in over 15 years, and will compete… Read More »